After 15 years at the helm of the Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Prof. Dr. Volker Haucke will step down as director of the institute on 1 January 2027. In the future, he will take on new challenges at the Hong Kong…
Pre-proposal Submission deadline: December 11th, 2026.
Two German innovation hubs will strengthen BioInnovation Institute (BII) and the Novo Nordisk Foundation’s pan-European CardioMetabolic Bridge initiative and accelerate the translation of promising cardiometabolic research into new treatments and…
The Spanish biotechnology company and German CDMO join forces to advance the development and manufacturing of VIVA-ELISA®, targeting its first Research Use Only (RUO) product in Q2 2027. The agreement strengthens VIVA's transition from scientific…
Using skin organoids, Emanuel Wyler and collaborators in Hamburg have traced how herpes simplex virus 1 infection progresses among neighboring skin cells. The work, published in “Science Advances,” might ultimately help researchers understand why a…
How can autonomous mobile robots help hospitals address the shortage of skilled workers and make logistical processes more efficient?
All five patients complete six-month follow-up without predefined prosthesis-related safety events
Eckert & Ziegler Therapeutics GmbH, wholly owned subsidiary of Eckert & Ziegler SE (ISIN DE0005659700, TecDAX), has received the manufacturing authorization for Actinium-225 (Ac-225).
People with public health insurance will likely be able to make their health data from the electronic patient record (ePA) available for research starting in November 2026. To ensure this is done in compliance with data protection regulations,…
Fabian Coscia and his team have published in “Nature Methods” an open-source workflow that makes Deep Visual Proteomics easier to use, adapt and scale. OpenDVP enables scientists to spatially map thousands of proteins inside cells and their cellular…
